Time-dependent alteration of cytoskeletal proteins in cerebral cortex of rat during 2,5-hexanedione-induced neuropathy

Neurochemical Research

Volumn 32, Issue 8, 2007, Pages 1407-1414

  Song, Fuyong ^a   Zhang, Cuili ^a   Yu, Sufang ^a   Zhao, Xiulan ^a   Yu, Lihua ^a   Xie, Keqin ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

2,5 Hexanedione; Neurofilaments; Toxic axonopathy

Indexed keywords

ACETONYLACETONE; ALPHA TUBULIN; BETA ACTIN; BETA TUBULIN; CYTOSKELETON PROTEIN; NEUROFILAMENT H PROTEIN; NEUROFILAMENT L PROTEIN; NEUROFILAMENT M PROTEIN; NEUROFILAMENT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; IMMUNOBLOTTING; INTOXICATION; MALE; NEUROFILAMENT; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; RAT; ULTRACENTRIFUGE;

ANIMALS; CEREBRAL CORTEX; CYTOSKELETAL PROTEINS; HEXANONES; MALE; NERVOUS SYSTEM DISEASES; NEUROTOXINS; RATS; RATS, WISTAR; TIME FACTORS;

RATTUS; RATTUS NORVEGICUS;

EID: 34250843789     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9325-x     Document Type: Article

References (36)

1. Altenkirch H, Mager J, Stoltenburg G, Helmbrecht J (1977) Toxic polyneuropathies after sniffing a glue thinner. J Neurol 214:137-152
2. Spencer PS, Schaumburg HH, Sabri MI, Veronesi B (1980) The enlarging view of hexacarbon neurotoxicity. Crit Rev Toxicol 7:279-356
3. Cavanagh JB, Bennetts RJ (1981) On the pattern of changes in the rat nervous system produced by 2,5 hexanediol. A topographical study by light microscopy. Brain 104:297-318
4. Couri D, Milks M (1982) Toxicity and metabolism of the neurotoxic hexacarbons n-hexane, 2-hexanone, and 2,5-hexanedione. Annu Rev Pharmacol Toxicol 22:145-166
5. Lehning EJ, Dyer KS, Jortner BS, LoPachin RM (1995) Axonal atrophy is a specific component of 2,5-hexanedione peripheral neuropathy. Toxicol Appl Pharmacol 135:58-66
6. Lehning EJ, Jortner BS, Fox JH, Arezzo JC, KitanoT, LoPachin RM (2000) Gamma-diketone peripheral neuropathy. I. Quality morphometric analyses of axonal atrophy and swelling. Toxicol Appl Pharmacol 165:127-140
7. Opanashuk LA, He DK, Lehning EJ, Lopachin RM (2001) Diketone peripheral neuropathy III. Neurofilament gene expression. Neurotoxicology 22:215-220
8. DeCaprio AP, O'Neill EA (1985) Alterations in rat axonal cytoskeletal proteins induced by in vitro and in vivo 2,5-hexanedione exposure. Toxicol Appl Pharmacol 78:235-247
9. Carden MJ, Lee VM, Schlaepfer WW (1986) 2,5-Hexanedione neuropathy is associated with the covalent crosslinking of neurofilament proteins. Neurochem Pathol 5:25-35
10. Lapadula DM, Suwita E, Abou-Donia MB (1988) Evidence for multiple mechanisms responsible for 2,5-hexanedione-induced neuropathy. Brain Res 458:123-131
11. LoPachin RM, He D, Reid ML, Opanashuk LA (2004) 2,5-Hexanedione-induced changes in monomeric neurofilament protein content of rat spinal cord fractions. Toxicol Appl Pharmacol 198:61-73
12. LoPachin RM, He D, Reid ML (2005) 2,5-Hexanedione-induced changes in the neurofilament subunit pools of rat peripheral nerve. Neurotoxicology 26:229-240
13. Zhang T, Han X, Zhao X, Zhao L, Zhang C, Yu L, Yu S, Xie K (2005) 2,5-Hexanedione induced reduction in protein content and mRNA expression of neurofilament in rat cerebral cortex. Environ Toxicol Pharmacol 20:92-98
14. LoPachin RM, Ross JF, Reid ML, Das S, Mansukhani S, Lehning EJ (2002) Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5-hexanedione. Neurotoxicology 23:95-110
15. Chiu FC, Norton WT (1982) Bulk preparation of CNS cytoskeleton and the separation of individual neurofilament proteins by gel filtration: dye-binding characteristics and amino acid compositions. J Neurochem 39:1252-1260
16. Tsuda M, Tashiro T, Komiya Y (1997) Increased solubility of highmolecular-mass neurofilament subunit by suppression of dephosphorylation: its relation to axonal transport. J Neurochem 68:2558-2565
17. Lee MK, Cleveland DW (1996) Neuronal intermediate filaments. Annu Rev Neurosci 19:187-217
18. Lee MK, Xu Z, Wong PC, Cleveland DW (1993) Neurofilaments are obligate heteropolymers in vivo. J Cell Biol 122:1337-1350
19. Cleveland DW, Monteiro MJ, Wong PC, Gill SR, Gearhart JD, Hoffman PN (1991) Involvement of neurofilaments in the radial growth of axons. J Cell Sci Suppl 15:85-95
20. Lee MK, Cleveland DW (1994) Neurofilament function and dysfunction: involvement in axonal growth and neuronal disease. Curr Opin Cell Biol 6:34-40
21. Micheva KD, Vallee A, Beaulieu C, Herman IM, Leclerc N (1998) Beta-actin is confined to structures having high capacity of remodeling in developing and adult rat cerebellum. Eur J Neurosci 10:3785-3798
22. Shea TB, Dahl DC, Nixon RA, Fischer I (1997) Triton-soluble phosphovariants of the heavy neurofilament subunit in developing and mature mouse central nervous system. J Neurosci Res 48:515-523
23. Shea TB, Sihag RK, Nixon RA (1990) Dynamics of phosphorylation and assembly of the high molecular weight neurofilament subunit in NB2a/d1 neuroblastoma. J Neurochem 55:1784-1792
24. Cohlberg JA, Hajarian H, Tran T, Alipourjeddi P, Noveen A (1995) Neurofilament protein heterotetramers as assembly intermediates. J Biol Chem 270:9334-9339
25. Arbuthnott ER, Boyd IA, Kalu KU (1980) Ultrastructural dimensions of myelinated peripheral nerve fibers in the cat and their relation to conduction velocity. J Physiol 308:125-137
26. Sakaguchi T, Okada M, Kitamura T, Kawasaki K (1993) Reduced diameter and conduction velocity of myelinated fibers in the sciatic nerve of a neurofilament-deficient mutant quail. Neurosci Lett 153:65-68
27. Banik NL, Hogan EL, Powers JM, Whetstine LJ (1982) Degradation of cytoskeletal proteins in spinal cord injury. Neurochem Res 7:1465-1475
28. Banik NL, Matzelle DC, Gantt-Wilford G, Osborne A, Hogan EL (1997) Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury. Brain Res 752:301-306
29. Ray SK, Hogan EL, Banik NL (2003) Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res Rev 42:169-185
30. Guo-Ross S, Yang E, Bondy SC (1998) Elevation of cerebral proteases after systemic administration of aluminum. Neurochem Int 33(3):277-282
31. Gupta RP, Abou-Donia MB (1996) Alterations in the neutral proteinase activities of central and peripheral nervous systems of acrylamide-, carbon disulfide-, or 2,5-hexanedione-treated rats. Mol Chem Neuropathol 29:53-66
32. Rao MV, Houseweart MK, Williamson TL, Crawford TO, Folmer J, Cleveland DW (1998) Neurofilament-dependent radial growth of motor axons and axonal organization of neurofilaments does not require the neurofilament heavy subunit (NF-H) or its phosphorylation. J Cell Biol 143:171-181
33. Moskowitz PF, Smith R, Pickett J, Frankfurter A, Oblinger MM (1993) Expression of the class III β-tubulin gene during axonal regeneration of rat dorsal root ganglion neurons. J Neurosci Res 34:129-134
34. Song FY, Yu SF, Zhao XL, Zhang CL, Xie KQ (2006) Carbon disulfide-induced changes in cytoskeleton protein content of rat cerebral cortex. Neurochem Res 31:71-79
35. Yagihashi S, Kamijo M, Watanabe K (1990) Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin rats. Am J Pathol 136:1365-1373
36. Liuzzi FJ, Bufton SM, Vinik AI (1998) Streptozotocin-induced diabetes mellitus causes changes in primary sensory neuronal cytoskeletal mRNA levels that mimic those caused by axotomy. Exp Neurol 154:381-388